People with type 1 diabetes, on average, have a shorter life expectancy by about 20 years. People with type 2 diabetes, on average, have a shorter life expectancy by about 10 years. After the analysis, the researchers found that the average person with type 1 diabetes was 42.8 years old and a life expectancy as of now of 32.6 years. By comparison, people of the same age without diabetes were expected to live 40.2 years from now.
For type 2 diabetes, the average patient was 65.4 years old and had a life expectancy as of now of 18.6 years. In comparison, patients of the same age without diabetes were expected to live within 20.3 years. Type 2 diabetes is a serious condition that can lead to life-threatening complications. Surprisingly, few studies have addressed the issue of life expectancy in type 1 diabetes.
These are the best and most recent studies we have been able to find. With many previous analyses of years of life lost that were based on older data, a team led by Dr. Adrian Heald, attempted to quantify the average reduction in life expectancy associated with type 1 and type diabetes, respectively, among patients using more recent data. There is a lack of data in death registries on death due to chronic or acute complications of diabetes (or lack of data on comorbidity).
New research suggests that a three-meal-a-day rather than six-meal-a-day approach brings more benefits to people with type 2 diabetes. According to the results of a new study, the younger a patient is when diagnosed with type 2 diabetes, the worse their prognosis for cardiovascular disease and the shorter their lifespan. Male diabetics show a slightly longer life expectancy than their counterparts in the non-diabetic population, with a marginal gain of 0.6 years over the entire observed period. Between the ages of 80 and 84, the total relative risk (RR) of death is 129%, 159% for diabetics and 171% for non-diabetics.
According to some estimates, there are approximately 2.5 percent of diabetes cases in Bulgaria that are not diagnosed, a fact that could further complicate segregation. After confirming the diagnosis by the endocrinologist, patients are more often monitored compared to the non-diabetic population, which allows diagnosis and treatment of diabetes-related complications, as well as a shorter time to develop complications compared to diabetics type 1.Livingstone, from the University of Dundee in Scotland, and colleagues compared the life expectancy of Scottish men and women aged 20 and older who had type 1 diabetes with that of a group of adults without the condition. The leading causes of death were cardiovascular disease, cancer, acute complications of diabetes and accidents or suicide. Recent improvements in life expectancy, due to superior diabetes control, have been absolutely enormous.
In the Scottish study, 21% of deaths among younger people (under 50) with type 1 diabetes occurred as a result of diabetic coma and related causes. However, since statistics were performed on the entire diabetic and non-diabetic population, all results reached significance with a small margin of error. Patients with type 2 DM have a longer life expectancy than patients with type 1 DM and the overall life expectancy of diabetics is equal to that of the non-diabetic population, which could suggest better control of the disease and its associated complications in Bulgaria. It is also worth noting that the Australian study found that much of the loss in average life expectancy was due to premature death from hypoglycemia, diabetic coma and kidney disease in younger patients.